The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

Klra  -  killer cell lectin-like receptor, subfamily A

Mus musculus

Synonyms: Ly-49, Ly49
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Klra

 

High impact information on Klra

  • A transcript map of the region identified 19 genes, including members of the killer cell lectin-like receptor family a (Klra, formerly Ly49; refs. 9-12), which encode inhibitory or activating NK cell receptors that interact with MHC class I molecules [6].
  • Expression of Ly49A and Ly49C, another member of the Ly49 family with distinct MHC specificity, define subpopulations of NK cells that are only partly overlapping [7].
  • Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation [8].
  • Here we employ a semiquantitative cell-cell adhesion assay as well as class I/peptide tetramers to provide a comprehensive analysis of specificities of Ly49 receptors for class I MHC molecules in eight MHC haplotypes [9].
  • The tetramer studies demonstrated that neither glycosylation nor coreceptors were necessary for class I binding to Ly49 receptors and uncovered peptide-specific recognition by a Ly49 receptor [9].
 

Biological context of Klra

 

Anatomical context of Klra

  • Also, administration of LTbetaR-immunoglobulin (Ig), which acts as a soluble receptor for LTalpha1beta2, resulted in reduced NK cell percentages but did not influence the Ly49 and CD94/NKG2 receptor acquisition on remaining NK cells [14].
  • A crucial step in murine natural killer (NK) cell development, mediated by bone marrow stromal cells, is the induction of Ly49 and CD94/NKG2 receptor expression [14].
  • NK cell function is regulated by Ly49 receptors in mice and killer cell Ig-like receptors in humans [2].
  • Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules [15].
  • By using primers based on the consensus sequences of the genomic clones, expression of Ly-49-related genes was detected by the polymerase chain reaction in various organs, including lung, kidney, liver, spleen, and thymus [16].
 

Associations of Klra with chemical compounds

  • Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase [17].
  • The acquisition of one Ly-49 receptor, Ly-49A is strictly dependent on the transcriptional trans-acting factor T cell-specific factor-1 (TCF-1) [18].
  • In the present study, we haveidentified this glycoprotein as a novel rat Ly49 receptor (Ly49i2) containing an immunoreceptor tyrosine-based inhibitory motif [19].
  • We recently reported that IL-7 preferentially promotes the in vitro expansion of a discrete MHC class I-dependent lymphocyte subset comprising both CD4+ and CD4-CD8- TCR alpha beta + cells bearing several NK cells markers such NK1.1 and Ly-49 [20].
  • Although we cannot exclude the possibility that NK cells participate in tumor cell killing in vivo, the presence of NK markers such as DX5, asialo GM1, Ly49, and CD94, and NKG2D on large numbers of eosinophils activated by eotaxin suggests that eosinophils function in such suppression of tumor cell growth [21].
 

Regulatory relationships of Klra

  • These data suggest that LTbetaR-mediated signals regulate Ly49 expression at least in part through the activation of IL-15 [22].
 

Other interactions of Klra

  • These results indicate that LTbetaR-mediated signals are not required for Ly49 and CD94/NKG2 receptor acquisition [14].
  • A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development [22].
  • Murine homologs of human NKG2 family members have not yet been identified, but we report here the existence of a murine NKG2D-like sequence that also maps to the murine NK complex near CD94 and Ly49 family members [23].
  • TCR and CD28 were re-expressed more rapidly than the inhibitory NK-cell receptors CD94/NKG2A and Ly49, temporally rendering the primed iNKT cells hyperreactive to ligand restimulation [24].
  • This inhibition of IFN-gamma production by MHC class I was independent of Ly-49 or CD94/NKG2A expression on NK cells [25].
 

Analytical, diagnostic and therapeutic context of Klra

  • Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens [26].
  • By examination of DNA from informative recombinant inbred mice with Southern blot analysis, we have determined that mNKR-P1 is encoded by a distinct gene that is genetically linked to the Ly-49 locus, lying within 0.5 centi-Morgan (cM) of Ly-49 [27].
  • We developed a single-cell RT-PCR method to analyze expression of all known Ly49 and NKG2A genes in individual NK cells and determined the receptor repertoires of NK cells from adult and neonatal (1-wk-old) C57BL/6 mice [28].
  • METHODS: We developed Ly49 receptor transgenic mice and studied the function of Ly49I(B6) in FVB.Ly49I(B6) transgenic mice using bone marrow transplantation assays to determine additional functional ligands for Ly49I(B6) [29].
  • These results show that the addition of a small number of paraformaldehyde fixed YAC cells to spleen cell cultures undergoing IL2 activation, resulted in a significant upregulation of Ly49 receptors and this process was dependent upon cell proliferative activity [30].

References

  1. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Desrosiers, M.P., Kielczewska, A., Loredo-Osti, J.C., Adam, S.G., Makrigiannis, A.P., Lemieux, S., Pham, T., Lodoen, M.B., Morgan, K., Lanier, L.L., Vidal, S.M. Nat. Genet. (2005) [Pubmed]
  2. Critical Residues at the Ly49 Natural Killer Receptor's Homodimer Interface Determine Functional Recognition of m157, a Mouse Cytomegalovirus MHC Class I-Like Protein. Kielczewska, A., Kim, H.S., Lanier, L.L., Dimasi, N., Vidal, S.M. J. Immunol. (2007) [Pubmed]
  3. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. Kane, K.P. J. Exp. Med. (1994) [Pubmed]
  4. Expansion of NK cells with reduction of their inhibitory Ly-49A, Ly-49C, and Ly-49G2 receptor-expressing subsets in a murine helminth infection: contribution to parasite control. Korten, S., Volkmann, L., Saeftel, M., Fischer, K., Taniguchi, M., Fleischer, B., Hoerauf, A. J. Immunol. (2002) [Pubmed]
  5. Induction of Ly-49 on an interspecies hybridoma between differentiation stage specific murine T cells and a rat T lymphoma. Nagasawa, R., Maruyama, N., Kubo, S., Yumura, W., Mitarai, T., Isoda, K., Kanagawa, O. Cell. Immunol. (1994) [Pubmed]
  6. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Lee, S.H., Girard, S., Macina, D., Busà, M., Zafer, A., Belouchi, A., Gros, P., Vidal, S.M. Nat. Genet. (2001) [Pubmed]
  7. Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Held, W., Roland, J., Raulet, D.H. Nature (1995) [Pubmed]
  8. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Saleh, A., Davies, G.E., Pascal, V., Wright, P.W., Hodge, D.L., Cho, E.H., Lockett, S.J., Abshari, M., Anderson, S.K. Immunity (2004) [Pubmed]
  9. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Hanke, T., Takizawa, H., McMahon, C.W., Busch, D.H., Pamer, E.G., Miller, J.D., Altman, J.D., Liu, Y., Cado, D., Lemonnier, F.A., Bjorkman, P.J., Raulet, D.H. Immunity (1999) [Pubmed]
  10. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family. Dimasi, N., Sawicki, M.W., Reineck, L.A., Li, Y., Natarajan, K., Margulies, D.H., Mariuzza, R.A. J. Mol. Biol. (2002) [Pubmed]
  11. Complete elucidation of a minimal class I MHC natural killer cell receptor haplotype. Anderson, S.K., Dewar, K., Goulet, M.L., Leveque, G., Makrigiannis, A.P. Genes Immun. (2005) [Pubmed]
  12. The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell gene complex on mouse chromosome 6. Forbes, C.A., Brown, M.G., Cho, R., Shellam, G.R., Yokoyama, W.M., Scalzo, A.A. Genomics (1997) [Pubmed]
  13. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Olsson, M.Y., Kärre, K., Sentman, C.L. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  14. Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-beta receptor expression. Stevenaert, F., Van Beneden, K., De Colvenaer, V., Franki, A.S., Debacker, V., Boterberg, T., Deforce, D., Pfeffer, K., Plum, J., Elewaut, D., Leclercq, G. Blood (2005) [Pubmed]
  15. Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. Anfossi, N., Robbins, S.H., Ugolini, S., Georgel, P., Hoebe, K., Bouneaud, C., Ronet, C., Kaser, A., DiCioccio, C.B., Tomasello, E., Blumberg, R.S., Beutler, B., Reiner, S.L., Alexopoulou, L., Lantz, O., Raulet, D.H., Brossay, L., Vivier, E. J. Immunol. (2004) [Pubmed]
  16. Ly-49 multigene family. New members of a superfamily of type II membrane proteins with lectin-like domains. Wong, S., Freeman, J.D., Kelleher, C., Mager, D., Takei, F. J. Immunol. (1991) [Pubmed]
  17. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. Mason, L.H., Gosselin, P., Anderson, S.K., Fogler, W.E., Ortaldo, J.R., McVicar, D.W. J. Immunol. (1997) [Pubmed]
  18. Positive and negative roles of the trans-acting T cell factor-1 for the acquisition of distinct Ly-49 MHC class I receptors by NK cells. Kunz, B., Held, W. J. Immunol. (2001) [Pubmed]
  19. Ly49i2 is an inhibitory rat natural killer cell receptor for an MHC class Ia molecule (RT1-A1c). Naper, C., Hayashi, S., Joly, E., Butcher, G.W., Rolstad, B., Vaage, J.T., Ryan, J.C. Eur. J. Immunol. (2002) [Pubmed]
  20. IL-7 reverses NK1+ T cell-defective IL-4 production in the non-obese diabetic mouse. Gombert, J.M., Tancrède-Bohin, E., Hameg, A., Leite-de-Moraes, M.C., Vicari, A., Bach, J.F., Herbelin, A. Int. Immunol. (1996) [Pubmed]
  21. Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma. Kataoka, S., Konishi, Y., Nishio, Y., Fujikawa-Adachi, K., Tominaga, A. DNA Cell Biol. (2004) [Pubmed]
  22. A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development. Lian, R.H., Chin, R.K., Nemeth, H.E., Libby, S.L., Fu, Y.X., Kumar, V. Eur. J. Immunol. (2004) [Pubmed]
  23. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Vance, R.E., Tanamachi, D.M., Hanke, T., Raulet, D.H. Eur. J. Immunol. (1997) [Pubmed]
  24. IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Ota, T., Takeda, K., Akiba, H., Hayakawa, Y., Ogasawara, K., Ikarashi, Y., Miyake, S., Wakasugi, H., Yamamura, T., Kronenberg, M., Raulet, D.H., Kinoshita, K., Yagita, H., Smyth, M.J., Okumura, K. Blood (2005) [Pubmed]
  25. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules. Kubota, A., Lian, R.H., Lohwasser, S., Salcedo, M., Takei, F. J. Immunol. (1999) [Pubmed]
  26. Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens. Raziuddin, A., Longo, D.L., Bennett, M., Winkler-Pickett, R., Ortaldo, J.R., Murphy, W.J. Blood (2002) [Pubmed]
  27. cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6. Yokoyama, W.M., Ryan, J.C., Hunter, J.J., Smith, H.R., Stark, M., Seaman, W.E. J. Immunol. (1991) [Pubmed]
  28. Diversity of NK cell receptor repertoire in adult and neonatal mice. Kubota, A., Kubota, S., Lohwasser, S., Mager, D.L., Takei, F. J. Immunol. (1999) [Pubmed]
  29. Definition of additional functional ligands for Ly49I(B6) using FVBLy49I(B6) transgenic mice and B6 natural killer cell effectors. Morris, M.A., Koulich, E., Liu, J., Arora, V., George, T.C., Schatzle, J.D., Kumar, V., Bennett, M. Transplantation (2002) [Pubmed]
  30. Abrogation of tumor induced Ly49 expression on mouse spleen cells by mitomycin C. Das, A., Saxena, R.K. Immunol. Lett. (2001) [Pubmed]
 
WikiGenes - Universities